Puget Sound Therapeutics

Puget Sound Therapeutics is a seed-stage startup developing a next-generation cell therapy to cure diseases of the corneal endothelium. Today, a donor derived corneal transplant is the only treatment for patients suffering from corneal blindness. Sadly, for every 70 people in need of a corneal transplant, only 1 is available. PST’s novel technology aims to generate thousands of allogenic cell therapies from the source material of a single donor cornea — providing a scalable new treatment option for the 13 million corneally blind around the globe who have no access to sight restoring transplants.